Short Term Effect of Cervical Mobilization vs Manipulation on Blood Pressure in Hypertensive Subjects

July 19, 2023 updated by: Alaa Mohamed El-Moatasem Mohamed, Cairo University

Short Term Effect of Cervical Mobilization vs Manipulation on Blood Pressure in Hypertensive Subjects( Randomized Control Trial)

Spinal pain or misalignment is a very common disorder affecting a significant number of populations resulting in substantial disability and economic burden. Various manual therapeutic techniques such as spinal manipulations and mobilizations can be used to treat and manage pain and movement dysfunctions such as spinal malalignments and associated complications. These manual therapeutic techniques can affect the cardiovascular parameters .

-

Study Overview

Status

Completed

Conditions

Detailed Description

Group A group (n=20). All participants will receive only single session of neck mobilization. Grade IV unilateral posteroanterior pressure and sustained extension to be applied restricted joints and muscle energy technique.

- Group B (n=20) will receive single session of neck manipulation with high-velocity, low-amplitude thrust over restricted joints (one at a time) with the goal of restoring normal range of motion in the joint.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Cairo, Egypt, 11432
        • Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

27 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • SBP ranging from 135 to 159 mm Hg or DBP ranging from 85 to 99 mm Hg over 3 qualifying BP screening visits
  • The age of participants will range from 27 to 60 years old.
  • Body mass index of participants will range between < 39 kg/m².

Exclusion Criteria:

  • cardiovascular diseases or surgery, including second- or third-degree heart block, angina pectoris, defibrillator, valvular disease, recent myocardial infarction, cardiac surgery in the past 12 months.
  • history of stroke.
  • body mass index (BMI) greater than 39 kg/m2.
  • pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: cervical mobilization
session will include3-5 repetitions of muscle energy technique in combination of facet joint mobilization of unilateral antro-posterior glide and extension repetitions
All participants will receive only single session of cervical mobilization
Active Comparator: cervical manipulation
patients will receive high velocity low amplitude thrust
All participants will receive only single session of cervical manipulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
systolic blood pressure measurement
Time Frame: it will be measured immediately before and after single session treatment
systolic pressure - the pressure when your heart pushes blood out and is measured by Mercury sphygmomanometer and stethoscope
it will be measured immediately before and after single session treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
diastolic blood pressure
Time Frame: it will be measured immediately before and after single session treatment
the pressure when your heart rests between beats is measured by Mercury sphygmomanometer and stethoscope
it will be measured immediately before and after single session treatment
oxygen saturation
Time Frame: it will be measured immediately before and after single session treatment
Oxygen saturation is a vital parameter to define blood oxygen content and oxygen delivery and is measured by pulse oximetry
it will be measured immediately before and after single session treatment
perfusion index
Time Frame: it will be measured immediately before and after single session treatment
Perfusion index is an indication of the pulse strength at the sensor site. The PI's values range from 0.02% for very weak pulse to 20% for extremely strong pulse.Perfusion index is normally monitored with pulse oximeters
it will be measured immediately before and after single session treatment
pain assessment
Time Frame: it will be measured immediately before and after single session treatment
The visual analog scale (VAS) is a tool widely used to measure pain
it will be measured immediately before and after single session treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2022

Primary Completion (Actual)

April 20, 2023

Study Completion (Actual)

July 4, 2023

Study Registration Dates

First Submitted

June 8, 2022

First Submitted That Met QC Criteria

June 14, 2022

First Posted (Actual)

June 15, 2022

Study Record Updates

Last Update Posted (Actual)

July 21, 2023

Last Update Submitted That Met QC Criteria

July 19, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T.REC/012/003253

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on cervical mobilization

3
Subscribe